MediWound Analyst Ratings
MediWound Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 209.52% | HC Wainwright & Co. | → $26 | Reiterates | Buy → Buy |
| 09/21/2023 | 209.52% | HC Wainwright & Co. | $23 → $26 | Maintains | Buy |
| 08/17/2023 | 328.57% | Oppenheimer | $63 → $36 | Maintains | Outperform |
| 08/17/2023 | 173.81% | HC Wainwright & Co. | → $23 | Reiterates | Buy → Buy |
| 05/31/2023 | 650% | Oppenheimer | → $63 | Reiterates | Outperform → Outperform |
| 05/31/2023 | 173.81% | HC Wainwright & Co. | → $23 | Reiterates | Buy → Buy |
| 03/17/2023 | 173.81% | HC Wainwright & Co. | → $23 | Reiterates | → Buy |
| 01/04/2023 | 173.81% | HC Wainwright & Co. | $5.5 → $23 | Maintains | Buy |
| 12/30/2022 | 197.62% | Cowen & Co. | $6 → $25 | Maintains | Outperform |
| 12/22/2022 | 197.62% | Maxim Group | → $25 | Initiates Coverage On | → Buy |
| 12/21/2022 | 650% | Oppenheimer | $9 → $63 | Maintains | Outperform |
| 11/16/2022 | -34.52% | HC Wainwright & Co. | $6 → $5.5 | Maintains | Buy |
| 07/18/2022 | -16.67% | Oppenheimer | → $7 | Assumes | → Outperform |
| 05/18/2022 | -4.76% | Wells Fargo | $7 → $8 | Maintains | Overweight |
| 03/21/2022 | -16.67% | Aegis Capital | $9 → $7 | Maintains | Buy |
| 08/17/2021 | 7.14% | Aegis Capital | $10 → $9 | Maintains | Buy |
| 08/11/2021 | -22.62% | HC Wainwright & Co. | $7 → $6.5 | Maintains | Buy |
| 03/02/2021 | 19.05% | Aegis Capital | → $10 | Initiates Coverage On | → Buy |
| 09/23/2020 | -28.57% | BTIG | → $6 | Initiates Coverage On | → Buy |
| 08/05/2019 | -34.52% | HC Wainwright & Co. | → $5.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/22/2023 | 209.52% | HC Wainwright & Co. | → 26 美元 | 重申 | 购买 → 购买 |
| 09/21/2023 | 209.52% | HC Wainwright & Co. | 23 美元 → 26 美元 | 维护 | 买 |
| 08/17/2023 | 328.57% | 奥本海默 | 63 美元 → 36 美元 | 维护 | 跑赢大盘 |
| 08/17/2023 | 173.81% | HC Wainwright & Co. | → 23 美元 | 重申 | 购买 → 购买 |
| 05/31/2023 | 650% | 奥本海默 | → 63 美元 | 重申 | 跑赢大盘 → 跑赢大盘 |
| 05/31/2023 | 173.81% | HC Wainwright & Co. | → 23 美元 | 重申 | 购买 → 购买 |
| 03/17/2023 | 173.81% | HC Wainwright & Co. | → 23 美元 | 重申 | → 购买 |
| 2023 年 4 月 1 日 | 173.81% | HC Wainwright & Co. | 5.5 美元 → 23 美元 | 维护 | 买 |
| 12/30/2022 | 197.62% | Cowen & Co. | 6 美元 → 25 美元 | 维护 | 跑赢大盘 |
| 2022 年 12 月 22 日 | 197.62% | Maxim 集团 | → 25 美元 | 启动覆盖范围开启 | → 购买 |
| 12/21/2022 | 650% | 奥本海默 | 9 美元 → 63 美元 | 维护 | 跑赢大盘 |
| 11/16/2022 | -34.52% | HC Wainwright & Co. | 6 美元 → 5.5 美元 | 维护 | 买 |
| 07/18/2022 | -16.67% | 奥本海默 | → 7 美元 | 假设 | → 跑赢大盘 |
| 05/18/2022 | -4.76% | 富国银行 | 7 美元 → 8 美元 | 维护 | 超重 |
| 03/21/2022 | -16.67% | 宙斯盾资本 | 9 美元 → 7 美元 | 维护 | 买 |
| 2021 年 8 月 17 日 | 7.14% | 宙斯盾资本 | 10 美元 → 9 美元 | 维护 | 买 |
| 08/11/2021 | -22.62% | HC Wainwright & Co. | 7 美元 → 6.5 美元 | 维护 | 买 |
| 2021 年 2 月 3 日 | 19.05% | 宙斯盾资本 | → 10 美元 | 启动覆盖范围开启 | → 购买 |
| 09/23/2020 | -28.57% | BTIG | → 6 美元 | 启动覆盖范围开启 | → 购买 |
| 2019 年 5 月 8 日 | -34.52% | HC Wainwright & Co. | → 5.5 美元 | 启动覆盖范围开启 | → 购买 |
What is the target price for MediWound (MDWD)?
MediWound (MDWD) 的目标价格是多少？
The latest price target for MediWound (NASDAQ: MDWD) was reported by HC Wainwright & Co. on November 22, 2023. The analyst firm set a price target for $26.00 expecting MDWD to rise to within 12 months (a possible 209.52% upside). 11 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年11月22日公布了MediWound（纳斯达克股票代码：MDWD）的最新目标股价。该分析公司将目标股价定为26.00美元，预计MDWD将在12个月内升至12个月内（可能上涨209.52％）。去年有11家分析公司公布了评级。
What is the most recent analyst rating for MediWound (MDWD)?
MediWound (MDWD) 的最新分析师评级是多少？
The latest analyst rating for MediWound (NASDAQ: MDWD) was provided by HC Wainwright & Co., and MediWound reiterated their buy rating.
HC Wainwright & Co. 提供了MediWound（纳斯达克股票代码：MDWD）的最新分析师评级，MediWound重申了买入评级。
When is the next analyst rating going to be posted or updated for MediWound (MDWD)?
MediWound（MDWD）的下一份分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MediWound, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MediWound was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与MediWound的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。MediWound的最新评级是在2023年11月22日公布的，因此您应该预计下一个评级将在2024年11月22日左右公布。
Is the Analyst Rating MediWound (MDWD) correct?
分析师对MediWound (MDWD) 的评级是否正确？
While ratings are subjective and will change, the latest MediWound (MDWD) rating was a reiterated with a price target of $0.00 to $26.00. The current price MediWound (MDWD) is trading at is $8.40, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的MediWound（MDWD）评级得到了重申，目标股价为0.00美元至26.00美元。MediWound（MDWD）目前的交易价格为8.40美元，在分析师的预测区间内。